Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 16

Response to Article “Autophagy Inhibits Inflammation via Down-Regulation of p38 MAPK/mTOR Signaling Cascade in Endothelial Cells” [Response to Letter]

Authors Zhou L, Wang J, Hou H, Li J, Li J, Liang J, Li J, Niu X, Hou R, Zhang K 

Received 28 March 2023

Accepted for publication 28 March 2023

Published 3 April 2023 Volume 2023:16 Pages 859—860

DOI https://doi.org/10.2147/CCID.S414606



Ling Zhou,1 Juanjuan Wang,1 Hui Hou,1 Jiao Li,1 Juan Li,1 Jiannan Liang,1 Junqin Li,1 Xuping Niu,1 Ruixia Hou,1 Kaiming Zhang2

1Shanxi Key Laboratory of Stem Cells for Immunological Dermatosis, Institute of Dermatology, Taiyuan Central Hospital of Shanxi Medical University, Taiyuan, People’s Republic of China; 2Shanxi Key Laboratory of Stem Cells for Immunological Dermatosis, Institute of Dermatology, Taiyuan Central Hospital, Taiyuan, People’s Republic of China

Correspondence: Kaiming Zhang, Email [email protected]


View the original paper by Dr Zhou and colleagues

This is in response to the Letter to the Editor


Dear editor

Thank you for your valuable comments on the paper. For the control problem, we made a blank control in the experiment, namely the control in the paper. Meanwhile, we also tested the indexes of the cells treated by the single autophagy inhibitor CQ and the p38 MAPK inhibitor SB203580. The results do not affect the final results and conclusions of the paper, but due to the space, we did not write the relevant results in the paper. In further studies we will add appropriate negative controls.

Disclosure

The authors report no conflicts of interest in this communication.

Creative Commons License © 2023 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.